Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025

May 12, 2025

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

7 Biggest Lithium-mining Companies

Ramp Metals Announces $4.5M Non-Brokered Private Placement Led...

Top 5 Canadian Mining Stocks This Week: Euro...

Springdale Continues to Build with Further Spectacular Diamond...

Augustus Minerals

Operator XR –Awarded $800,000 Government Contract

Astral & Maximus to Merge Via Recommended Takeover...

High Grade Gold Intercepts Confirm Kpali Discovery

Gold Reaches New Price Record, Then Pulls Back;...

McEwen, Meding: Buying Gold Juniors Now, Watching Copper...

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

Trump’s 20th week in office to include White House meeting with European...
Ukraine’s drone attack the latest in a series of daring David versus Goliath hits against Russian targets
Woman accused of killing in-laws with toxic mushrooms takes stand for first time
Harmony Gold to Acquire MAC Copper in US$1.03 Billion Deal
Ore Reserve Quadruples for Rhyolite Ridge Project; Reaffirms Robust Project Economics

Categories

Business (1,672)
Investing (4,995)
Politics (7,861)
Uncategorized (2)
World (6,378)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

Acceleration of RAD204 Phase 1 dose escalation trial

Multiple New Multi-Commodity Targets

A bridge builder and quiet reformer. How Pope Leo will lead the Catholic Church

You may also like